-
1
المؤلفون: Dreier, Maren, Borutta, Birgit, Stahmeyer, Jona, Krauth, Christian, Walter, Ulla
المصدر: GMS Health Technology Assessment, Vol 6, p Doc07 (2010)
GMS Health Technology Assessment
GMS Health Technology Assessment; VOL: 6; DOC07 /20100614/مصطلحات موضوعية: EPIDEMIOLOGISCHE STUDIEN, ÖKONOMIE, TECHNOLOGY ASSESSMENT, BIOMEDICAL, Meta-Analyse, risk of bias, Skalen, science, METHODIK, component ratings, Qualität, lcsh:R723-726, HTA, standard, Instrument, 610 Medical sciences, Medicine, Validität von Ergebnissen, Verzerrung, lcsh:R855-855.5, quality, Qualitätsbewertung, METHODS, Checklisten, Bewertungsinstrumente, STÖRFAKTOREN (EPIDEMIOLOGIE), evidenzbasierte Medizin, BIAS (EPIDEMIOLOGIE), lcsh:Medical technology, quality assessment, systematic reviews, scales, Metaanalyse, Beobachtungsstudien, Article, components, QUALITÄT DES GESUNDHEITSWESENS, quality assessment tools, health technology assessment, klinische Studien, observational studies, checklists, Epidemiologie, study quality, clinical trials, Gesundheitsökonomie, Komponenten, health economic studies, Studienqualität, Verzerrungspotenzial, META-ANALYSIS AS TOPIC, Wissenschaft, lcsh:Medical philosophy. Medical ethics, validity, bias, diagnostic studies, QUALITY OF HEALTH CARE, Methoden, epidemiologische, Verzerrung, systematische (Epidemiologie), REPRODUCIBILITY OF RESULTS, methodologic quality, gesundheitsökonomische Studien, CONFOUNDING FACTORS (EPIDEMIOLOGY), quality appraisal, assessment tools, health economics, Komponentenbewertung, assessment quality, Interventionsstudien, Diagnosestudien, Verzerrung, statistische (Epidemiologie), tool, Bewerungskriterien, Validität, Bewertungsqualität, ddc: 610, evaluation criteria, epidemiology, evidence-based medicine, Methodik, Evaluations, interventional studies, QAT, EBM, TECHNIKFOLGEN-ABSCHÄTZUNG, BIOMEDIZINISCHE, EPIDEMIOLOGIC STUDIES, QBI, critical appraisal, Studien, methodische Qualität, systematische Übersichtsarbeiten, BIAS (EPIDEMIOLOGY), item, ECONOMICS, REPRODUZIERBARKEIT, ERGEBNIS, Studienbewertung, studies, confounding, meta-analysis, study assessment, Qualitätsbewertunginstrument
-
2
المؤلفون: Baumeister, Harald
المصدر: GMS German Medical Science; VOL: 6; DOC03 /20080602/
GMS German Medical Science
GMS German Medical Science, Vol 6, p Doc03 (2008)مصطلحات موضوعية: validity, DIABETES MELLITUS/epidemiology, HEALTH STATUS, ATEMWEGSKRANKHEITEN/Epidemiologie, lcsh:Medicine, OSTEOARTHRITIS/epidemiology, REPRODUCIBILITY OF RESULTS, SELF CONCEPT, OSTEOPOROSE/Epidemiologie, RESPIRATORY TRACT DISEASES/epidemiology, DIAGNOSTIK, SELBSTKONZEPT, BRONCHITIS, CHRONISCHE/Epidemiologie, OSTEOPOROSIS/epidemiology, HYPERTENSION/epidemiology, SCHILDDRÜSENKRANKHEITEN/Epidemiologie, BRONCHITIS, CHRONIC/epidemiology, self-report, Validität, GICHT/Epidemiologie, somatic diseases, HEALTH SURVEYS, ddc: 610, GERMANY, ASTHMA/epidemiology, HYPERTONIE/Epidemiologie, GESUNDHEITSERHEBUNGEN, HERZ-KREISLAUF-KRANKHEITEN/Epidemiologie, Selbstbericht, Epidemiologie, DIAGNOSIS, DATENINTERPRETATION, STATISTISCHE, Article, HEART FAILURE/epidemiology, OSTEOARTHROSE/Epidemiologie, DATA INTERPRETATION, STATISTICAL, ARTHRITIS/Epidemiologie, REPRODUZIERBARKEIT, ERGEBNIS, lcsh:R, ARTHRITIS/epidemiology, ASTHMA/Epidemiologie, DEUTSCHLAND, TUMOREN/Epidemiologie, CARDIOVASCULAR DISEASES/epidemiology, THYROID DISEASES/epidemiology, somatische Erkrankungen, GESUNDHEITSZUSTAND, DIABETES MELLITUS/Epidemiologie, NEOPLASMS/epidemiology, GOUT/epidemiology
-
3
المؤلفون: Reinauer, Hans, Dux, László, Akerboom, Theodorus, Kaiser, Patricia
المصدر: GMS German Medical Science; VOL: 4; DOC06 /20060921/
GMS German Medical Science, Vol 4, p Doc06 (2006)مصطلحات موضوعية: HbA1c, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS, CHROMATOGRAPHY, HIGH PRESSURE LIQUID, trifluoroacetic acid, lcsh:Medicine, reference measurement procedure, HÄMOGLOBIN A, GLYCOSYLIERTES, REFERENCE STANDARDS, REPRODUCIBILITY OF RESULTS, Referenzmessverfahren, PEPTIDES/analysis, SENSITIVITY AND SPECIFICITY, SENSITIVITÄT UND SPEZIFITÄT, PUFFER, ACETONITRILE, HPLC-ESI-MS, HEMOGLOBIN A, GLYCOSYLATED/*analysis, BUFFERS, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS-/*Methoden, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION/*methods, HEMOGLOBIN A, GLYCOSYLATED, ACETONITRILES, REPRODUZIERBARKEIT, ERGEBNIS, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS-/*Methoden, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION, lcsh:R, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS, ddc: 610, CHROMATOGRAPHY, HIGH PRESSURE LIQUID/*methods, REFERENZSTANDARDS, HÄMOGLOBIN A, GLYCOSYLIERTES/*Analyse, PEPTIDE/Analyse, TRIFLUORESSIGSÄURE
-
4
المصدر: GMS German Medical Science
GMS German Medical Science; VOL: 4; DOC01 /20060118/
GMS German Medical Science, Vol 4, p Doc01 (2006)مصطلحات موضوعية: TACROLIMUS, SIROLIMUS/*Blut, CYCLOSPORIN/*Blut, TACROLISMUS, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS, CHROMATOGRAPHY, HIGH PRESSURE LIQUID, lcsh:Medicine, immunosuppressive drugs, Immunosuppressiva, SIROLIMUS, REPRODUCIBILITY OF RESULTS, Cs+ adducts, Tacrolimus, Article, SENSITIVITY AND SPECIFICITY, SENSITIVITÄT UND SPEZIFITÄT, TACROLIMUS/*blood, SPEKTRALANALYSE, MASSEN-/*Methoden, IMMUNSUPPRESSIVA/*Blut, 32-desmethoxyrapamycin, Cs+-Addukte, LC-MS/MS, CYCLOSPORIN, SPECTRUM ANALYSIS, MASS, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS-/*Methoden, Sirolimus, SPEKTRALANALYSE, MASSEN, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION/*methods, TACROLISMUS/*Blut, REPRODUZIERBARKEIT, ERGEBNIS, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS-/*Methoden, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION, lcsh:R, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS, everolimus, IMMUNSUPPRESSIVA, cyclosporin D, IMMUNOSUPPRESSIVE AGENTS/*blood, SPECTRUM ANALYSIS, MASS/*methods, ddc: 610, CHROMATOGRAPHY, HIGH PRESSURE LIQUID/*methods, SIROLIMUS/*blood, IMMUNOSUPPRESSIVE AGENTS, Cyclosporine, CYCLOSPORINE, Immunosuppressive Agents, CYCLOSPORINE/*blood
-
5
المؤلفون: Reinauer, H, Wood, WG
المصدر: GMS German Medical Science; VOL: 3; DOC02 /20050530/
مصطلحات موضوعية: TUMORMARKER, BIOLOGISCHE/Analyse, Calcitonin, THYROGLOBULIN/analysis, CALCITONIN/analysis, KARZINOEMBRYONALES ANTIGEN/Analyse, REPRODUCIBILITY OF RESULTS, CORTICOTROPIN/analysis, TUMOR MARKERS, BIOLOGICAL/*standards, CALCITONIN/Analyse, standardisation, Thyroglobulin, CHORIONIC GONADOTROPIN/analysis, COMPARATIVE STUDY, tumour markers, CA-72-4 ANTIGEN/analysis, TUMOR MARKERS, BIOLOGICAL/analysis, immunoassay, diagnostic sensitivity, PROLACTIN/Analyse, QUALITY CONTROL, THYREOGLOBULIN/Analyse, CHORIONGONADOTROPIN, BETA-UNTEREINHEIT, HUMANES/Analyse, PROLACTIN/analysis, CARCINOEMBRYONIC ANTIGEN/analysis, accuracy, CORTICOTROPIN/Analyse, Human Growth Hormone, CHORIONGONADOTROPIN/Analyse, MENSCH, QUALITÄTSKONTROLLE, HUMANS, HUMANES WACHSTUMSHORMON/Analyse, TUMOR MARKERS, BIOLOGICAL, external quality assessment (EQA), Prolactin, ALPHA-FETOPROTEINE/Analyse, TUMORMARKER, BIOLOGISCHE/*Standard, Analyse, TUMORMARKER, BIOLOGISCHE, ddc: 610, HUMAN GROWTH HORMONE/analysis, ALPHA-FETOPROTEINS/analysis, REPRODUZIERBARKEIT, ERGEBNIS, method comparison, Corticotropin, VERGLEICHENDE STUDIE, diagnostic specificity, precision, CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN/analysis
-
6Electronic Resource
Additional Titles: Vergleich von Bewertungsinstrumenten für die Studienqualität von Primär- und Sekundärstudien zur Verwendung für HTA-Berichte im deutschsprachigen Raum
المؤلفون: Dreier, M, Borutta, B, Stahmeyer, J, Krauth, C, Walter, U
المصدر: GMS Health Technology Assessment; VOL: 6; DOC07 /20100614/
مصطلحات الفهرس: QUALITY OF HEALTH CARE, REPRODUCIBILITY OF RESULTS, BIAS (EPIDEMIOLOGY), CONFOUNDING FACTORS (EPIDEMIOLOGY), EPIDEMIOLOGIC STUDIES, META-ANALYSIS AS TOPIC, METHODS, TECHNOLOGY ASSESSMENT, BIOMEDICAL, ECONOMICS, QUALITÄT DES GESUNDHEITSWESENS, REPRODUZIERBARKEIT, ERGEBNIS, BIAS (EPIDEMIOLOGIE), STÖRFAKTOREN (EPIDEMIOLOGIE), EPIDEMIOLOGISCHE STUDIEN, METAANALYSE, METHODIK, TECHNIKFOLGEN-ABSCHÄTZUNG, BIOMEDIZINISCHE, ÖKONOMIE, quality assessment, assessment quality, quality assessment tools, assessment tools, study quality, study assessment, clinical trials, evaluation criteria, methodologic quality, validity, quality, science, risk of bias, bias, confounding, systematic reviews, health technology assessment, HTA, health economics, health economic studies, critical appraisal, quality appraisal, checklists, scales, component ratings, components, tool, studies, interventional studies, observational studies, diagnostic studies, item, meta-analysis, QAT, EBM, evidence-based medicine, standard, epidemiology, Validität von Ergebnissen, Bias (Epidemiologie), Verzerrung, statistische (Epidemiologie), Verzerrung, systematische (Epidemiologie), Methoden, epidemiologische, Methodik, Evaluations, Studienqualität, Studienbewertung, klinische Studien, Bewerungskriterien, Qualitätsbewertunginstrument, Qualitätsbewertung, Verzerrungspotenzial, Verzerrung, Bias, Validität, Confounding, Health Technology Assessment, systematische Übersichtsarbeiten, Gesundheitsökonomie, gesundheitsökonomische Studien, Checklisten, Skalen, Komponentenbewertung, Komponenten, Instrument, Studien, Interventionsstudien, Beobachtungsstudien, Diagnosestudien, Item, Metaanalyse, Meta-Analyse, QBI, evidenzbasierte Medizin, Bewertungsqualität, Bewertungsinstrumente, Standard, Qualität, Wissenschaft, methodische Qualität, Epidemiologie, ddc: 610, article
-
7Electronic Resource
Additional Titles: 'Weiß nicht'-Antworten in Bezug auf Fragen nach dem Vorliegen einer körperlichen Erkrankung sollten nicht als 'Nein'-Antworten betrachtet werden
المؤلفون: Baumeister, H
المصدر: GMS German Medical Science; VOL: 6; DOC03 /20080602/
مصطلحات الفهرس: SELF CONCEPT, HEALTH STATUS, DIAGNOSIS, HEALTH SURVEYS, GERMANY, DATA INTERPRETATION, STATISTICAL, REPRODUCIBILITY OF RESULTS, NEOPLASMS/epidemiology, HEART FAILURE/epidemiology, CARDIOVASCULAR DISEASES/epidemiology, HYPERTENSION/epidemiology, ASTHMA/epidemiology, BRONCHITIS, CHRONIC/epidemiology, DIABETES MELLITUS/epidemiology, THYROID DISEASES/epidemiology, OSTEOPOROSIS/epidemiology, GOUT/epidemiology, RESPIRATORY TRACT DISEASES/epidemiology, OSTEOARTHRITIS/epidemiology, ARTHRITIS/epidemiology, SELBSTKONZEPT, GESUNDHEITSZUSTAND, DIAGNOSTIK, GESUNDHEITSERHEBUNGEN, DEUTSCHLAND, DATENINTERPRETATION, STATISTISCHE, REPRODUZIERBARKEIT, ERGEBNIS, TUMOREN/Epidemiologie, Epidemiologie, HERZ-KREISLAUF-KRANKHEITEN/Epidemiologie, HYPERTONIE/Epidemiologie, ASTHMA/Epidemiologie, BRONCHITIS, CHRONISCHE/Epidemiologie, DIABETES MELLITUS/Epidemiologie, SCHILDDRÜSENKRANKHEITEN/Epidemiologie, OSTEOPOROSE/Epidemiologie, GICHT/Epidemiologie, ATEMWEGSKRANKHEITEN/Epidemiologie, OSTEOARTHROSE/Epidemiologie, ARTHRITIS/Epidemiologie, somatic diseases, validity, self-report, somatische Erkrankungen, Validität, Selbstbericht, ddc: 610, article
URL:
http://www.egms.de/en/journals/gms/2008-6/000048.shtml
Baumeister H, Härter M. Mental disorders in patients with obesity in comparison with healthy probands. Int J Obes. 2007;31(7):1155-64.
Bullinger M. German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med. 1995;41(10):1359-66.
Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI. Impact of office systems and improvement strategies on costs of care for adults with diabetes. Diabetes Care. 2006;29(6):1242-8.
Groothuis PA, Whitehead JC. Does don´t know mean no? Analysis of "don´t know" responses in dichotomous choice contingent valuation questions. Appl Econ. 2002;34(15):1935-40.
Jacobi F, Wittchen HU, Hölting C, Sommer S, Lieb R, Höfler M, Pfister H. Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res. 2002;11(1):1-18.
Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR. Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. J Clin Epidemiol. 2007;60(6):634-42.
Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57(10):1096-103.
Robert Koch-Institut. Public Use File. Bundes-Gesundheitssurvey 1998 - Kernsurvey. Berlin: RKI; 2000.
StataCorp. Stata Statistical Software, release 9.0. College Station, TX: Stata Corporation; 2005. -
8Electronic Resource
Additional Titles: Modifikation des IFCC Referenzmessverfahrens zur Bestimmung von HbA1c mittels HPLC-ESI-MS
المؤلفون: Kaiser, P, Akerboom, T, Dux, L, Reinauer, H
المصدر: GMS German Medical Science; VOL: 4; DOC06 /20060921/
مصطلحات الفهرس: REPRODUCIBILITY OF RESULTS, SENSITIVITY AND SPECIFICITY, CHROMATOGRAPHY, HIGH PRESSURE LIQUID, CHROMATOGRAPHY, HIGH PRESSURE LIQUID/*methods, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION/*methods, REFERENCE STANDARDS, HEMOGLOBIN A, GLYCOSYLATED, HEMOGLOBIN A, GLYCOSYLATED/*analysis, TRIFLUOROACETIC ACID, ACETONITRILES, BUFFERS, PEPTIDES/analysis, REPRODUZIERBARKEIT, ERGEBNIS, SENSITIVITÄT UND SPEZIFITÄT, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS-/*Methoden, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS-/*Methoden, REFERENZSTANDARDS, HÄMOGLOBIN A, GLYCOSYLIERTES, HÄMOGLOBIN A, GLYCOSYLIERTES/*Analyse, TRIFLUORESSIGSÄURE, ACETONITRILE, PUFFER, PEPTIDE/Analyse, HbA1c, reference measurement procedure, HPLC-ESI-MS, Referenzmessverfahren, trifluoroacetic acid, acetonitrile, ddc: 610, article
URL:
http://www.egms.de/en/journals/gms/2006-4/000035.shtml
EN 14136: 2004 Use of external quality assessment schemes in the assessment of the performance of in vitro diagnostic examination procedures.
Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen [Guideline of the German Medical Association for Quality Assurance of Quantitative Analyses in Laboratory Medicine]. Dtsch Ärztebl. 2001;98(42):A2747-A2759.
Finke A, Kobold U, Hoelzel W, Weykamp C, Miedema K, Jeppsson JO. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med. 1998;36(5):299-308.
ISO 15193: 2005 In vitro diagnostic medical devices - Measurement of quantities in samples of biological origin - Presentation of reference measurement procedures.
Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C; International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002;40(1):78-89. -
9Electronic Resource
Additional Titles: Neuer Ansatz zur Bestimmung von Immunsuppressiva unter Einsatz von HPLC-MS/MS und Cs+-Addukten
المؤلفون: Kaiser, P, Akerboom, T, Wood, WG, Reinauer, H
المصدر: GMS German Medical Science; VOL: 4; DOC01 /20060118/
مصطلحات الفهرس: REPRODUCIBILITY OF RESULTS, SENSITIVITY AND SPECIFICITY, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION, SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION/*methods, SPECTRUM ANALYSIS, MASS, SPECTRUM ANALYSIS, MASS/*methods, CHROMATOGRAPHY, HIGH PRESSURE LIQUID, CHROMATOGRAPHY, HIGH PRESSURE LIQUID/*methods, IMMUNOSUPPRESSIVE AGENTS, IMMUNOSUPPRESSIVE AGENTS/*blood, TACROLIMUS, TACROLIMUS/*blood, CYCLOSPORINE, CYCLOSPORINE/*blood, SIROLIMUS, SIROLIMUS/*blood, REPRODUZIERBARKEIT, ERGEBNIS, SENSITIVITÄT UND SPEZIFITÄT, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS, MASSENSPEKTROMETRIE, ELEKTROSPRAYIONISATIONS-/*Methoden, SPEKTRALANALYSE, MASSEN, SPEKTRALANALYSE, MASSEN-/*Methoden, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS, CHROMATOGRAPHIE, HOCHDRUCK-FLÜSSIGKEITS-/*Methoden, IMMUNSUPPRESSIVA, IMMUNSUPPRESSIVA/*Blut, TACROLISMUS, TACROLISMUS/*Blut, CYCLOSPORIN, CYCLOSPORIN/*Blut, SIROLIMUS/*Blut, immunosuppressive drugs, LC-MS/MS, Cs+ adducts, Immunosuppressiva, Cs+-Addukte, Immunosuppressive Agents, Tacrolimus, Cyclosporine, Sirolimus, 32-desmethoxyrapamycin, everolimus, cyclosporin D, ddc: 610, article
URL:
http://www.egms.de/en/journals/gms/2006-4/000030.shtml
Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta. 2004;346(2):181-90.
Kaiser P, Akerboom T, Wood WG, Reinauer H. A novel LC-IDMS/MS method for the determination of the cardiac glycosides digoxin and digitoxin using Cs+ adducts. Clin Lab. 2006: in press.
Kaiser P, Kramer U, Meissner D, Kress M, Wood WG, Reinauer H. Determination of the cardiac glycosides digoxin and digitoxin by liquid chromatography combined with isotope-dilution mass spectrometry (LC-IDMS)-a candidate reference measurement procedure. Clin Lab. 2003;49(7-8):329-43.
Kirchner GI, Vidal C, Winkler M, Mueller L, Jacobsen W, Franzke A, Sewing KF. LC/ESI-MS allows simultaneous and specific quantification of SDZ RAD and cyclosporine, including groups of their metabolites in human blood. Ther Drug Monit. 1999;21(1):116-22.
Streit F, Armstrong VW, Oellerich M. Mass interferences in quantification of cyclosporin using tandem mass spectrometry without chromatography. Ther Drug Monit. 2003;25(4):506. Abstract 80.
Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem. 2002;48(6 Pt 1):955-8.
Taylor PJ, Brown SR, Cooper DP, Salm P, Morris MR, Pillans PI, Lynch SV. Evaluation of 3 internal standards for the measurement of cyclosporin by HPLC-mass spectrometry. Clin Chem. 2005;51(10):1890-3.
Tuominen J, Suortti T, Ishikawa K, Lundell J, Koga Y. Separation of cyclosporins by high-performance liquid chromatography and mass spectrometric study of cyclosporin metabolites. Rapid Commun Mass Spectrom. 1998;12(16):1085-91.
Vogeser M, Fleischer C, Meiser B, Groetzner J, Spöhrer U, Seidel D. Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction. Clin Chem Lab Med. 2002;40(1):40-5.
Vogeser M, Spöhrer U. Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med. 2005;43(4):400-2.
Vogeser M, Zachoval R, Spöhrer U, Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit. 2001;23(6):722-4. -
10Electronic Resource
Additional Titles: state of the art and consequences for estimating diagnostic sensitivity and specificity
Ringversuche für Tumormarker
eine Istanalyse mit Folgerung für die Berechnung der diagnostischen Sensitivität und Spezifitätالمؤلفون: Reinauer, H, Wood, WG
المصدر: GMS German Medical Science; VOL: 3; DOC02 /20050530/
مصطلحات الفهرس: COMPARATIVE STUDY, HUMANS, QUALITY CONTROL, REPRODUCIBILITY OF RESULTS, CORTICOTROPIN/analysis, HUMAN GROWTH HORMONE/analysis, PROLACTIN/analysis, CHORIONIC GONADOTROPIN/analysis, THYROGLOBULIN/analysis, CALCITONIN/analysis, CARCINOEMBRYONIC ANTIGEN/analysis, CA-72-4 ANTIGEN/analysis, CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN/analysis, ALPHA-FETOPROTEINS/analysis, TUMOR MARKERS, BIOLOGICAL/analysis, TUMOR MARKERS, BIOLOGICAL, TUMOR MARKERS, BIOLOGICAL/*standards, VERGLEICHENDE STUDIE, MENSCH, QUALITÄTSKONTROLLE, REPRODUZIERBARKEIT, ERGEBNIS, CORTICOTROPIN/Analyse, HUMANES WACHSTUMSHORMON/Analyse, PROLACTIN/Analyse, CHORIONGONADOTROPIN/Analyse, THYREOGLOBULIN/Analyse, CALCITONIN/Analyse, KARZINOEMBRYONALES ANTIGEN/Analyse, Analyse, CHORIONGONADOTROPIN, BETA-UNTEREINHEIT, HUMANES/Analyse, ALPHA-FETOPROTEINE/Analyse, TUMORMARKER, BIOLOGISCHE/Analyse, TUMORMARKER, BIOLOGISCHE, TUMORMARKER, BIOLOGISCHE/*Standard, external quality assessment (EQA), tumour markers, precision, accuracy, standardisation, method comparison, diagnostic specificity, diagnostic sensitivity, immunoassay, Thyroglobulin, Corticotropin, Human Growth Hormone, Prolactin, Calcitonin, ddc: 610, article
URL:
http://www.egms.de/en/journals/gms/2005-3/000020.shtml
Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331-7.
Berson SA, Yalow RS. Radioimmunoassay of ACTH in plasma. J Clin Invest 1968;47(12):2725-51.
Bloomfield GA, Holdaway IM, Corrin B, Ratcliffe JG, Rees GM, Ellison M, Rees LH. Lung tumours and ACTH production. Clin Endocrinol (Oxf). 1977;6(2):95-104.
Bodenmüller H, Ofenloch-Hähnle B, Lane EB, Dessauer A, Böttger V, Donie F. Lung cancer-associated keratin 19 fragments:development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1. Int J Biol Markers. 1994;9(2):75-81
Brawer MK. Prostate-specific antigen: current status. CA Cancer J Clin. 1999;49(5):264-81.
Bundesärztekammer. Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Gemäß Beschluss des Vorstandes der Bundesärztekammer vom 24. August 2001, veröffentlicht im Deutschen Ärzteblatt 98, Heft 42, 19. Oktober 2001, Seite A 2747 - 2759. Zuletzt geändert durch Beschluss des Vorstandes der Bundesärztekammer vom 14. November 2003, veröffentlicht im Deutschen Ärzteblatt 100, Heft 50, 12. Dezember 2003, Seite A 3335 - 3338. Dtsch Ärztebl. 2003;100(50):A3335-A3338. Available from: http://www.bundesaerztekammer.de/30/Richtlinien/Richtidx/Labor2002/RiliLabor.pdf
Charters AC, Odell WD, Thompson JC. Anterior pituitary function during surgical stress and convalescence. Radioimmunoassay measurement of blood TSH, LH, FSH and growth hormone. J Clin Endocrinol Metab. 1969;29(1):63-71.
Cornelisse CJ, Cornelis RS, Devilee P. Genes responsible for familial breast cancer. Pathol Res Pract. 1996;192(7):684-93.
Del Villano BC, Zurawski VR Jr. The carbohydrate antigenic determinant 19-9 (CA 19-9):a monoclonal antibody defined tumor marker. Lab Res Methods Biol Med. 1983;8:269-82.
Duffy MJ. Evidence for the clinical use of tumour markers. Ann Clin Biochem. 2004;41(Pt 5):370-7.
Feldman JM. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. Gastroenterology. 1978;75(6):1109-14.
Gang Y, Adachi I, Ohkura H, Yamamoto H, Mizuguchi Y, Abe K. CA 15-3 is present as a novel tumour marker in the sera of patients with breast cancer and other malignancies. Gan To Kagaku Ryoho. 1985;12(12):2379-86.
Gold P, Freedman SO. Demonstration of tumor specific antigens in human colonic carcinoma by immunologic tolerance and absorption technique. J Exp Med. 1965;121:439-62.
Hall JM, Freedman L, Guenther C, Lee MK, Weber JL, Black DM, King MC. Closing in on a breast cancer gene on chromosome 17q. Amer J Hum Genet. 1992;50(6):1235-42.
Herrero-Zabaleta ME, Gautier R, Burtin P, Daher N, Bara J. Monoclonal antibody against sialylated Lewis(a) antigen. Bull Cancer. 1987;74(4):387-96.
Hirohashi S, Shimosato Y, Ino Y, Tome Y, Watanabe M, Hirota T, Itabashi M. Distribution of blood group antigens and CA 19-9 in gastric cancers and non-neoplastic gastric mucosa. Gann. 1984;75(6):540-7.
Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Eng J Med. 2004;351(6):533-42.
Huggins C, Hodges CV. Studies on prostatic cancer. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293-7.
Inazawa J, Inoue J, Imoto I. Comparative genomic hybridisation (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci. 2004;95(7):559-63.
Krupey J, Gold P, Freedman SO:Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J Exp Med. 1968;128(3):387-98.
Lamerz R. PSA (Prostata-spezifisches Anitigen). In: Thomas L, ed. Labor und Diagnose. 5. ed. Frankfurt/Main: TH-Books Verlagsgesellschaft; 1998. p. 1004-8 (Kap. 34.14).
Midgley AR Jr, Niswender GD, Ram JS. Hapten-radioimmunoassay: a general procedure for the estimation of steroidal and other haptenic substances. Steroids 1969;13(6):731-7.
Mitrunen K, Pettersson K, Piironen T, Bjork T, Lilja H, Lövgren T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem. 1995;41(8 Pt 1):1115-20.
Morrison C, Farrar W, Kneile J, Williams N, Liu-Stratton Y, Bakaletz A, Aldred MA, Eng C. Molecular classification of parathyroid neoplasia by gene expression profiling. Am J Pathol. 2004;165(2):565-76.
Murphy BE. Radioassays of non-antigenic hormones. Trans Assoc Am Physicians. 1968;81:92-103.
Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, Gentleman R, Gullans SR, Wei LJ, Wilcox M. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol. 2001;83(2):177-85.
Ohuchi N, Takahashi K, Matoba N, Mori S. A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4. Gan To Kagaku Ryoho. 1988;15(9):2761-6.
Pour PM, Tempero MM, Takasaki H, Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Expression of blood group related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res. 1988;48(19):5422-6.
Rushworth AG, Orr AH, Bagshawe KD. The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system. Br J Cancer. 1968;22(2):253-7.
Schutte M, Rozenblum E, Moskaluk CA, Guan X, Hoque AT, Hahn SA, da Costa LT, de Jong PJ, Kern SE. An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res. 1995;55(29):4570-4.
Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004;172(4 Pt 1):1297-301.
Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer:assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991;51(1):222-6.
Stieber P, Thomas L, Lamerz R, Raue F, Grauer A, Nollau P et al. Tumormarker (Kapitel 28). In: Thomas L, ed. Labor und Diagnose - Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. 6. Aufl. Frankfurt/Main: TH-Books Verlagsgesellschaft mbH; 2005. p. 1291-1366.
Tashjian AH Jr, Melvin EW. Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. N Eng J Med. 1968;279(6):279-83.
Thomas L, Lüthgens M, Wagener C, Lamerz R, Mann K, Tatra G et al. Tumormarker. In: Thomas L, ed. Labor und Diagnose - Indikation und Bewertung von Laborbefunden in die medizinische Diagnostik. 3., überarb. u. erw. Aufl. Marburg: Med. Verlagsgesellschaft; 1988. p. 945-1015.
Turler K, Kaser H. Quantitative fluorimetric determination of urinary dopa and its significance for the diagnosis of neural crest tumours. Clin Chim Acta. 1971;32(1):41-51.
Van Niekerk CC, Boerman OC, Ramaekers FC, Poels LG. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas. Am J Pathol. 1991;138(2):455-63.
Vessella RL, Lange PH. Issues in the assessment of PSA immunoassays. Urol Clin North Am. 1993;20(4):607-19.
von Euler U, Lishajko F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961;51:348-55.
Whipple ME, Mendez E, Farwell DG, Agoff SN, Chen C. A genomic predictor of oral squamous cell carcinoma. Laryngoscope. 2004;114(8):1346-54.
Wood WG, Steinhoff J, Kessler AC. Anomalous tumour marker concentrations in renal transplant patients. Eur J Clin Chem Clin Biochem. 1993;31(2):75-82.
Wood WG, van der Sloot E, Böhle A. The establishment and evaluation of luminescent-labelled immunometric assays for prostate-specific antigen-alpha 1-antichymotrypsin complexes in serum. Eur J Clin Chem Clin Biochem. 1991;29(12):787-94.
Wood WG, Steinhoff J, Gutekunst R. Sense and nonsense in determination of tumour markers in serum - results with potentially disastrous consequences. In: Klapdor R, ed. Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the nineties. München: Zuckschwerdt; 1992. p. 305-12.
Wood WG, Mainwaring-Burton RW. The development and evaluation of a semi-automated assay for catecholamines suitable for plasma and urine. Clin Chim Acta. 1975;61(3):297-308.
Wu JT, Wilson LW. Development of a microplate ELISA for free PSA and PSA-ACT complex in serum. J Clin Lab Anal 1995;9(4):252-60.